FF:12246-129H5: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity= | |sample_ethnicity= | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0044424;intracellular part;0!GO:0005622;intracellular;0!GO:0005737;cytoplasm;7.68197449099395e-94!GO:0005515;protein binding;6.43054570403037e-71!GO:0043227;membrane-bound organelle;5.73846759444491e-60!GO:0043231;intracellular membrane-bound organelle;8.64590299320597e-60!GO:0043226;organelle;4.11639236137758e-56!GO:0043229;intracellular organelle;1.25015953933281e-55!GO:0044444;cytoplasmic part;5.7654050149165e-50!GO:0044422;organelle part;1.43137224799317e-48!GO:0044446;intracellular organelle part;1.52317928933349e-47!GO:0032991;macromolecular complex;2.38813671858778e-40!GO:0019538;protein metabolic process;4.63919193802313e-39!GO:0044260;cellular macromolecule metabolic process;2.56345361482032e-37!GO:0044267;cellular protein metabolic process;9.00376685102309e-37!GO:0044237;cellular metabolic process;7.43803555987332e-36!GO:0044238;primary metabolic process;2.04102667803123e-34!GO:0043170;macromolecule metabolic process;2.04102667803123e-34!GO:0003723;RNA binding;7.26870520121561e-32!GO:0044428;nuclear part;2.49738816807695e-31!GO:0012501;programmed cell death;3.12992648059573e-30!GO:0006915;apoptosis;5.63897422666656e-30!GO:0008219;cell death;8.66889849585635e-30!GO:0016265;death;8.66889849585635e-30!GO:0033036;macromolecule localization;1.29463114300212e-29!GO:0045184;establishment of protein localization;1.1167591433302e-28!GO:0015031;protein transport;1.09350163070236e-27!GO:0008104;protein localization;3.80415436824052e-27!GO:0043234;protein complex;4.59369439548641e-26!GO:0016071;mRNA metabolic process;1.29126576610068e-25!GO:0005829;cytosol;5.77366841898178e-25!GO:0016043;cellular component organization and biogenesis;1.67507027019143e-23!GO:0005634;nucleus;2.47461019408688e-22!GO:0043687;post-translational protein modification;4.59989990872715e-22!GO:0043233;organelle lumen;4.59989990872715e-22!GO:0031974;membrane-enclosed lumen;4.59989990872715e-22!GO:0031090;organelle membrane;1.12147573961207e-21!GO:0007242;intracellular signaling cascade;1.17618776845076e-21!GO:0043412;biopolymer modification;2.23675053842126e-21!GO:0031981;nuclear lumen;5.25951027810253e-21!GO:0006397;mRNA processing;6.21933527178387e-21!GO:0030529;ribonucleoprotein complex;7.08338400277114e-21!GO:0006464;protein modification process;1.33008649106138e-20!GO:0000166;nucleotide binding;1.3519619321982e-19!GO:0042981;regulation of apoptosis;1.74775600344837e-19!GO:0043067;regulation of programmed cell death;1.81661308220875e-19!GO:0002376;immune system process;3.93420704327429e-19!GO:0008380;RNA splicing;8.27304239068007e-19!GO:0006793;phosphorus metabolic process;1.57653529846906e-18!GO:0006796;phosphate metabolic process;1.57653529846906e-18!GO:0043283;biopolymer metabolic process;1.83719273906236e-18!GO:0006396;RNA processing;2.20184787810722e-18!GO:0016310;phosphorylation;4.76346038791263e-18!GO:0005654;nucleoplasm;7.51888414200934e-18!GO:0007243;protein kinase cascade;8.03880766004186e-18!GO:0006412;translation;3.93908857452009e-17!GO:0065003;macromolecular complex assembly;5.89504947237988e-17!GO:0008134;transcription factor binding;7.15789735402975e-17!GO:0032553;ribonucleotide binding;1.2041708620012e-16!GO:0032555;purine ribonucleotide binding;1.2041708620012e-16!GO:0006512;ubiquitin cycle;1.45088708520488e-16!GO:0046907;intracellular transport;2.11374201666686e-16!GO:0017076;purine nucleotide binding;5.01499772128187e-16!GO:0065009;regulation of a molecular function;1.51425806382835e-15!GO:0017111;nucleoside-triphosphatase activity;1.68030155587377e-15!GO:0016462;pyrophosphatase activity;2.00701314272215e-15!GO:0005524;ATP binding;2.47902246125106e-15!GO:0006886;intracellular protein transport;2.90816147117464e-15!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;2.9177502801563e-15!GO:0016817;hydrolase activity, acting on acid anhydrides;2.93750490459285e-15!GO:0006955;immune response;4.56783548226889e-15!GO:0032559;adenyl ribonucleotide binding;8.52981611938545e-15!GO:0022607;cellular component assembly;1.12678198387452e-14!GO:0048523;negative regulation of cellular process;1.23609806092621e-14!GO:0044451;nucleoplasm part;2.05768095772016e-14!GO:0044265;cellular macromolecule catabolic process;3.10516322481809e-14!GO:0005794;Golgi apparatus;4.15704314317036e-14!GO:0009059;macromolecule biosynthetic process;4.9435487149264e-14!GO:0030554;adenyl nucleotide binding;5.31572191156745e-14!GO:0006950;response to stress;8.14003622883351e-14!GO:0048519;negative regulation of biological process;2.32833933844364e-13!GO:0016192;vesicle-mediated transport;2.81507730169852e-13!GO:0051641;cellular localization;2.99286326972801e-13!GO:0051649;establishment of cellular localization;3.42517260204738e-13!GO:0005681;spliceosome;4.00086308904516e-13!GO:0009058;biosynthetic process;5.27080957634566e-13!GO:0012505;endomembrane system;7.24234627349053e-13!GO:0044249;cellular biosynthetic process;4.72320340572838e-12!GO:0043285;biopolymer catabolic process;7.16447881628014e-12!GO:0019941;modification-dependent protein catabolic process;9.41001579846909e-12!GO:0043632;modification-dependent macromolecule catabolic process;9.41001579846909e-12!GO:0016604;nuclear body;1.29438743633508e-11!GO:0043069;negative regulation of programmed cell death;1.3621853525435e-11!GO:0006913;nucleocytoplasmic transport;1.47691917935685e-11!GO:0009057;macromolecule catabolic process;1.56163795227796e-11!GO:0006511;ubiquitin-dependent protein catabolic process;1.64039295880291e-11!GO:0050790;regulation of catalytic activity;1.69004966162719e-11!GO:0043066;negative regulation of apoptosis;1.97071829131406e-11!GO:0051603;proteolysis involved in cellular protein catabolic process;1.99392871061037e-11!GO:0051169;nuclear transport;2.39710013184529e-11!GO:0044257;cellular protein catabolic process;2.90136634533759e-11!GO:0006996;organelle organization and biogenesis;3.74263799185809e-11!GO:0016887;ATPase activity;7.39934634592266e-11!GO:0044248;cellular catabolic process;1.45000633228408e-10!GO:0009607;response to biotic stimulus;1.63519291813192e-10!GO:0004674;protein serine/threonine kinase activity;1.73753079412714e-10!GO:0006259;DNA metabolic process;1.73753079412714e-10!GO:0003712;transcription cofactor activity;1.79977106363622e-10!GO:0005830;cytosolic ribosome (sensu Eukaryota);1.93770324677712e-10!GO:0048518;positive regulation of biological process;2.04758582208738e-10!GO:0042623;ATPase activity, coupled;3.88788003303266e-10!GO:0007249;I-kappaB kinase/NF-kappaB cascade;3.90635992403573e-10!GO:0048468;cell development;3.99577096994558e-10!GO:0048522;positive regulation of cellular process;4.1460429505942e-10!GO:0016787;hydrolase activity;4.75353910756029e-10!GO:0044445;cytosolic part;5.21080919732526e-10!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;7.30094046012795e-10!GO:0016773;phosphotransferase activity, alcohol group as acceptor;9.01019532912225e-10!GO:0016607;nuclear speck;1.00463580280208e-09!GO:0016772;transferase activity, transferring phosphorus-containing groups;1.5176369681645e-09!GO:0009615;response to virus;1.53904610641309e-09!GO:0019899;enzyme binding;1.72613705411049e-09!GO:0006916;anti-apoptosis;1.85531782657613e-09!GO:0006119;oxidative phosphorylation;2.05778098027297e-09!GO:0006366;transcription from RNA polymerase II promoter;2.18990514012781e-09!GO:0008639;small protein conjugating enzyme activity;2.19763458163598e-09!GO:0005768;endosome;2.76508360986699e-09!GO:0006325;establishment and/or maintenance of chromatin architecture;3.00942342183317e-09!GO:0030163;protein catabolic process;4.06237052313577e-09!GO:0022618;protein-RNA complex assembly;4.1739331412293e-09!GO:0004842;ubiquitin-protein ligase activity;5.16512826513529e-09!GO:0006468;protein amino acid phosphorylation;6.20637208617202e-09!GO:0016301;kinase activity;6.76800022561377e-09!GO:0051726;regulation of cell cycle;7.50704039121646e-09!GO:0005840;ribosome;8.57546435219889e-09!GO:0033279;ribosomal subunit;8.61087490261393e-09!GO:0006323;DNA packaging;1.0185462384745e-08!GO:0005773;vacuole;1.05829987298741e-08!GO:0051246;regulation of protein metabolic process;1.08421267176124e-08!GO:0031967;organelle envelope;1.36419276128073e-08!GO:0048770;pigment granule;1.45766378012231e-08!GO:0042470;melanosome;1.45766378012231e-08!GO:0000074;regulation of progression through cell cycle;1.5439709218685e-08!GO:0031975;envelope;1.69699054615769e-08!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;1.78555388709852e-08!GO:0043065;positive regulation of apoptosis;1.81907394210449e-08!GO:0043068;positive regulation of programmed cell death;2.02927077585857e-08!GO:0019787;small conjugating protein ligase activity;2.15368679234426e-08!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);3.48517721282833e-08!GO:0006605;protein targeting;4.65199815133015e-08!GO:0000502;proteasome complex (sensu Eukaryota);5.05696831856001e-08!GO:0019829;cation-transporting ATPase activity;5.35116194093498e-08!GO:0016568;chromatin modification;5.76038283616339e-08!GO:0003743;translation initiation factor activity;6.66890328769684e-08!GO:0006952;defense response;8.00001158305734e-08!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;1.15799944338316e-07!GO:0043492;ATPase activity, coupled to movement of substances;1.18622152935434e-07!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;1.22196804530973e-07!GO:0015399;primary active transmembrane transporter activity;1.22196804530973e-07!GO:0003735;structural constituent of ribosome;1.29301586682816e-07!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;1.54393379769623e-07!GO:0003713;transcription coactivator activity;1.66540016105468e-07!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;1.76339616893551e-07!GO:0008135;translation factor activity, nucleic acid binding;1.80121472918833e-07!GO:0010467;gene expression;2.02739218004983e-07!GO:0005783;endoplasmic reticulum;2.09865487317072e-07!GO:0022613;ribonucleoprotein complex biogenesis and assembly;2.24979535455729e-07!GO:0007264;small GTPase mediated signal transduction;2.55851189815699e-07!GO:0016874;ligase activity;2.60136858756666e-07!GO:0006917;induction of apoptosis;2.69307630811355e-07!GO:0012502;induction of programmed cell death;3.86393349303352e-07!GO:0006457;protein folding;4.25548757225782e-07!GO:0006413;translational initiation;5.19656996452477e-07!GO:0060090;molecular adaptor activity;6.75144980042099e-07!GO:0006954;inflammatory response;7.28426756443024e-07!GO:0007049;cell cycle;8.02091356214413e-07!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;8.09275993250224e-07!GO:0051707;response to other organism;8.26161183860698e-07!GO:0045786;negative regulation of progression through cell cycle;8.46324298308421e-07!GO:0006446;regulation of translational initiation;8.62627963394158e-07!GO:0005739;mitochondrion;9.00906976763971e-07!GO:0051276;chromosome organization and biogenesis;9.37303985557584e-07!GO:0016740;transferase activity;1.14249036493029e-06!GO:0005770;late endosome;1.22906428374457e-06!GO:0015935;small ribosomal subunit;1.38681814969264e-06!GO:0007165;signal transduction;1.38681814969264e-06!GO:0015078;hydrogen ion transmembrane transporter activity;1.50851101018917e-06!GO:0009889;regulation of biosynthetic process;1.50851101018917e-06!GO:0006606;protein import into nucleus;1.55494782737835e-06!GO:0031324;negative regulation of cellular metabolic process;1.5761932446782e-06!GO:0051082;unfolded protein binding;1.61098864746957e-06!GO:0051170;nuclear import;1.65411460259943e-06!GO:0000323;lytic vacuole;1.65411460259943e-06!GO:0005764;lysosome;1.65411460259943e-06!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;1.65411460259943e-06!GO:0009056;catabolic process;1.9356956464466e-06!GO:0004672;protein kinase activity;2.18432252604588e-06!GO:0006417;regulation of translation;2.59571152534146e-06!GO:0008047;enzyme activator activity;2.62848473280016e-06!GO:0044431;Golgi apparatus part;2.9879536375584e-06!GO:0015986;ATP synthesis coupled proton transport;3.46482565912289e-06!GO:0015985;energy coupled proton transport, down electrochemical gradient;3.46482565912289e-06!GO:0045859;regulation of protein kinase activity;3.70153557766234e-06!GO:0009966;regulation of signal transduction;3.81675807397945e-06!GO:0016469;proton-transporting two-sector ATPase complex;3.92908744872221e-06!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;4.20499470169468e-06!GO:0005774;vacuolar membrane;4.21608062023067e-06!GO:0015077;monovalent inorganic cation transmembrane transporter activity;4.88066516494663e-06!GO:0050794;regulation of cellular process;4.92931883672625e-06!GO:0008632;apoptotic program;5.00812953680236e-06!GO:0004386;helicase activity;5.16268867694373e-06!GO:0016564;transcription repressor activity;5.67251090652253e-06!GO:0008026;ATP-dependent helicase activity;6.02390180458482e-06!GO:0006754;ATP biosynthetic process;6.02390180458482e-06!GO:0006753;nucleoside phosphate metabolic process;6.02390180458482e-06!GO:0009967;positive regulation of signal transduction;6.2240178937795e-06!GO:0043549;regulation of kinase activity;6.2240178937795e-06!GO:0016563;transcription activator activity;7.2411142337132e-06!GO:0005070;SH3/SH2 adaptor activity;7.40483936637525e-06!GO:0031326;regulation of cellular biosynthetic process;8.15634935548448e-06!GO:0044437;vacuolar part;8.45517981755012e-06!GO:0000398;nuclear mRNA splicing, via spliceosome;8.60850274413098e-06!GO:0000375;RNA splicing, via transesterification reactions;8.60850274413098e-06!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;8.60850274413098e-06!GO:0051789;response to protein stimulus;8.60850274413098e-06!GO:0006986;response to unfolded protein;8.60850274413098e-06!GO:0048193;Golgi vesicle transport;8.60850274413098e-06!GO:0051338;regulation of transferase activity;8.7913702785478e-06!GO:0046034;ATP metabolic process;9.22269758595163e-06!GO:0005635;nuclear envelope;1.00963129361738e-05!GO:0065004;protein-DNA complex assembly;1.15834253272596e-05!GO:0005057;receptor signaling protein activity;1.32298061179235e-05!GO:0051336;regulation of hydrolase activity;1.32298061179235e-05!GO:0032446;protein modification by small protein conjugation;1.41455988341097e-05!GO:0044440;endosomal part;1.45334888621723e-05!GO:0010008;endosome membrane;1.45334888621723e-05!GO:0044432;endoplasmic reticulum part;1.48558989423126e-05!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;1.49804147713722e-05!GO:0009892;negative regulation of metabolic process;1.68716062881033e-05!GO:0048475;coated membrane;1.69256343266255e-05!GO:0030117;membrane coat;1.69256343266255e-05!GO:0045321;leukocyte activation;1.79907046475553e-05!GO:0043085;positive regulation of catalytic activity;1.80225317672527e-05!GO:0009150;purine ribonucleotide metabolic process;2.44601128958066e-05!GO:0044429;mitochondrial part;2.47414879886351e-05!GO:0031965;nuclear membrane;2.67210518462583e-05!GO:0030120;vesicle coat;2.70372883198186e-05!GO:0030662;coated vesicle membrane;2.70372883198186e-05!GO:0016879;ligase activity, forming carbon-nitrogen bonds;2.77718314033125e-05!GO:0042175;nuclear envelope-endoplasmic reticulum network;2.97825315503628e-05!GO:0016481;negative regulation of transcription;3.14149545432988e-05!GO:0005789;endoplasmic reticulum membrane;3.51894085367331e-05!GO:0016567;protein ubiquitination;3.88831600413127e-05!GO:0009152;purine ribonucleotide biosynthetic process;3.89088515330619e-05!GO:0031982;vesicle;3.93781562541894e-05!GO:0016881;acid-amino acid ligase activity;4.00001582947017e-05!GO:0050789;regulation of biological process;4.25250163046051e-05!GO:0065007;biological regulation;4.27788835395401e-05!GO:0044453;nuclear membrane part;4.54116123099877e-05!GO:0003924;GTPase activity;4.63561080764177e-05!GO:0043228;non-membrane-bound organelle;4.90005412255486e-05!GO:0043232;intracellular non-membrane-bound organelle;4.90005412255486e-05!GO:0051186;cofactor metabolic process;4.98331452776688e-05!GO:0008565;protein transporter activity;5.8146003250587e-05!GO:0009259;ribonucleotide metabolic process;5.83085077482667e-05!GO:0005746;mitochondrial respiratory chain;6.47417981450301e-05!GO:0009893;positive regulation of metabolic process;6.56502551212936e-05!GO:0005793;ER-Golgi intermediate compartment;6.86559384062996e-05!GO:0005765;lysosomal membrane;7.01159276175894e-05!GO:0009205;purine ribonucleoside triphosphate metabolic process;7.39254890817769e-05!GO:0009144;purine nucleoside triphosphate metabolic process;7.39254890817769e-05!GO:0000139;Golgi membrane;7.49389202316607e-05!GO:0009199;ribonucleoside triphosphate metabolic process;7.64937765723642e-05!GO:0003714;transcription corepressor activity;7.70242055581924e-05!GO:0042110;T cell activation;7.71216111189614e-05!GO:0019221;cytokine and chemokine mediated signaling pathway;8.09251817470962e-05!GO:0016197;endosome transport;8.09251817470962e-05!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;8.34306889766705e-05!GO:0009145;purine nucleoside triphosphate biosynthetic process;8.34306889766705e-05!GO:0017038;protein import;8.48747269738458e-05!GO:0044455;mitochondrial membrane part;8.48747269738458e-05!GO:0030695;GTPase regulator activity;8.52737998465684e-05!GO:0009142;nucleoside triphosphate biosynthetic process;8.79387116889255e-05!GO:0009201;ribonucleoside triphosphate biosynthetic process;8.79387116889255e-05!GO:0009141;nucleoside triphosphate metabolic process;8.81031137593443e-05!GO:0009611;response to wounding;8.98848201337139e-05!GO:0006818;hydrogen transport;9.55214598161319e-05!GO:0051168;nuclear export;0.000113023415787694!GO:0006333;chromatin assembly or disassembly;0.000124204273200677!GO:0001775;cell activation;0.000125248267884381!GO:0022890;inorganic cation transmembrane transporter activity;0.000128111691042452!GO:0006461;protein complex assembly;0.000128111691042452!GO:0031252;leading edge;0.000133032716849818!GO:0007265;Ras protein signal transduction;0.000141642784121403!GO:0022402;cell cycle process;0.00014853918744525!GO:0015992;proton transport;0.000162716823309088!GO:0009260;ribonucleotide biosynthetic process;0.000172804620812784!GO:0031410;cytoplasmic vesicle;0.000187862183557248!GO:0000151;ubiquitin ligase complex;0.000190494052622333!GO:0001816;cytokine production;0.000194243047335053!GO:0002764;immune response-regulating signal transduction;0.000197068062244109!GO:0016044;membrane organization and biogenesis;0.00021727965777366!GO:0006888;ER to Golgi vesicle-mediated transport;0.000222395142708007!GO:0006163;purine nucleotide metabolic process;0.000234583043556171!GO:0006402;mRNA catabolic process;0.000272868125323793!GO:0005885;Arp2/3 protein complex;0.000284034833976867!GO:0051251;positive regulation of lymphocyte activation;0.000298136945047294!GO:0050136;NADH dehydrogenase (quinone) activity;0.000298136945047294!GO:0003954;NADH dehydrogenase activity;0.000298136945047294!GO:0008137;NADH dehydrogenase (ubiquinone) activity;0.000298136945047294!GO:0006732;coenzyme metabolic process;0.00032048026436927!GO:0006752;group transfer coenzyme metabolic process;0.00032460214636314!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.00032510710815543!GO:0003724;RNA helicase activity;0.000333575075434941!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);0.000343863066999768!GO:0005740;mitochondrial envelope;0.000357794857404088!GO:0019866;organelle inner membrane;0.000379871650330925!GO:0002757;immune response-activating signal transduction;0.00038685040544167!GO:0006403;RNA localization;0.000416242713739014!GO:0006164;purine nucleotide biosynthetic process;0.000420120942048535!GO:0031988;membrane-bound vesicle;0.000420120942048535!GO:0050657;nucleic acid transport;0.000460394848836082!GO:0051236;establishment of RNA localization;0.000460394848836082!GO:0050658;RNA transport;0.000460394848836082!GO:0042802;identical protein binding;0.000514530686996916!GO:0001819;positive regulation of cytokine production;0.000514530686996916!GO:0046822;regulation of nucleocytoplasmic transport;0.000521758724312792!GO:0005839;proteasome core complex (sensu Eukaryota);0.000526300093343448!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;0.000529956601185408!GO:0007050;cell cycle arrest;0.000561968241354571!GO:0005769;early endosome;0.000563101769675752!GO:0046649;lymphocyte activation;0.00056349576484304!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;0.000566872090848679!GO:0006914;autophagy;0.000584315127465768!GO:0006974;response to DNA damage stimulus;0.000588920424489673!GO:0031966;mitochondrial membrane;0.000607296010878795!GO:0046519;sphingoid metabolic process;0.000626777905162072!GO:0043281;regulation of caspase activity;0.00063632814078944!GO:0006672;ceramide metabolic process;0.000656684441577161!GO:0006401;RNA catabolic process;0.000696824744057628!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;0.000723274055042623!GO:0044262;cellular carbohydrate metabolic process;0.000755667242101379!GO:0005798;Golgi-associated vesicle;0.000760957647248152!GO:0043566;structure-specific DNA binding;0.000787868587111334!GO:0002768;immune response-regulating cell surface receptor signaling pathway;0.000788786277532749!GO:0051090;regulation of transcription factor activity;0.000821259913652662!GO:0003729;mRNA binding;0.00086812281724263!GO:0006919;caspase activation;0.0008818722142444!GO:0005096;GTPase activator activity;0.00092259918378456!GO:0031901;early endosome membrane;0.000944269742031216!GO:0005083;small GTPase regulator activity;0.00096884199730782!GO:0016023;cytoplasmic membrane-bound vesicle;0.00101903738188456!GO:0043280;positive regulation of caspase activity;0.00102326608892356!GO:0001817;regulation of cytokine production;0.00116919730533055!GO:0002252;immune effector process;0.00119504992119081!GO:0030036;actin cytoskeleton organization and biogenesis;0.00121084981810237!GO:0031325;positive regulation of cellular metabolic process;0.00124380678376629!GO:0004298;threonine endopeptidase activity;0.00124380678376629!GO:0005525;GTP binding;0.00124766529968611!GO:0051345;positive regulation of hydrolase activity;0.00127707116206248!GO:0046983;protein dimerization activity;0.00132309161482911!GO:0002429;immune response-activating cell surface receptor signaling pathway;0.00155116271425218!GO:0042775;organelle ATP synthesis coupled electron transport;0.00157488294090045!GO:0042773;ATP synthesis coupled electron transport;0.00157488294090045!GO:0006613;cotranslational protein targeting to membrane;0.00164260160558985!GO:0008186;RNA-dependent ATPase activity;0.00168516524135951!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00170811631182371!GO:0006352;transcription initiation;0.0018462484824875!GO:0005637;nuclear inner membrane;0.0018462484824875!GO:0031902;late endosome membrane;0.00190235620638116!GO:0045893;positive regulation of transcription, DNA-dependent;0.00190408451570139!GO:0002274;myeloid leukocyte activation;0.00192539109598393!GO:0051223;regulation of protein transport;0.00203628621888077!GO:0030964;NADH dehydrogenase complex (quinone);0.00206208887153605!GO:0045271;respiratory chain complex I;0.00206208887153605!GO:0005747;mitochondrial respiratory chain complex I;0.00206208887153605!GO:0045941;positive regulation of transcription;0.00206208887153605!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.00211951946560203!GO:0000785;chromatin;0.00222322682294959!GO:0006897;endocytosis;0.00225581346730227!GO:0010324;membrane invagination;0.00225581346730227!GO:0050870;positive regulation of T cell activation;0.00256612306909577!GO:0019901;protein kinase binding;0.00256612306909577!GO:0002474;antigen processing and presentation of peptide antigen via MHC class I;0.00256873748833577!GO:0030658;transport vesicle membrane;0.00260354963502965!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;0.00267382164598065!GO:0015934;large ribosomal subunit;0.00281171549951017!GO:0005643;nuclear pore;0.00292696648586938!GO:0000287;magnesium ion binding;0.00297122357330755!GO:0030099;myeloid cell differentiation;0.00303717915954472!GO:0006935;chemotaxis;0.00319348274561223!GO:0042330;taxis;0.00319348274561223!GO:0004437;inositol or phosphatidylinositol phosphatase activity;0.00347174328281678!GO:0000165;MAPKKK cascade;0.00355858082324171!GO:0008637;apoptotic mitochondrial changes;0.00371519987057606!GO:0033157;regulation of intracellular protein transport;0.00373346009804419!GO:0042306;regulation of protein import into nucleus;0.00373346009804419!GO:0002682;regulation of immune system process;0.00375069106701801!GO:0042221;response to chemical stimulus;0.00376823222227603!GO:0051028;mRNA transport;0.00413339947223617!GO:0002250;adaptive immune response;0.00418365057392508!GO:0002460;adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;0.00418365057392508!GO:0033367;protein localization in mast cell secretory granule;0.00418776644324852!GO:0033365;protein localization in organelle;0.00418776644324852!GO:0033371;T cell secretory granule organization and biogenesis;0.00418776644324852!GO:0033373;maintenance of protease localization in mast cell secretory granule;0.00418776644324852!GO:0033375;protease localization in T cell secretory granule;0.00418776644324852!GO:0042629;mast cell granule;0.00418776644324852!GO:0033377;maintenance of protein localization in T cell secretory granule;0.00418776644324852!GO:0033364;mast cell secretory granule organization and biogenesis;0.00418776644324852!GO:0033380;granzyme B localization in T cell secretory granule;0.00418776644324852!GO:0033379;maintenance of protease localization in T cell secretory granule;0.00418776644324852!GO:0033370;maintenance of protein localization in mast cell secretory granule;0.00418776644324852!GO:0033368;protease localization in mast cell secretory granule;0.00418776644324852!GO:0033366;protein localization in secretory granule;0.00418776644324852!GO:0033382;maintenance of granzyme B localization in T cell secretory granule;0.00418776644324852!GO:0033374;protein localization in T cell secretory granule;0.00418776644324852!GO:0004004;ATP-dependent RNA helicase activity;0.00418929506182907!GO:0018193;peptidyl-amino acid modification;0.00418929506182907!GO:0019900;kinase binding;0.00421081950177689!GO:0006611;protein export from nucleus;0.00427527344717012!GO:0000079;regulation of cyclin-dependent protein kinase activity;0.00457396322160596!GO:0008286;insulin receptor signaling pathway;0.00467481116520266!GO:0003697;single-stranded DNA binding;0.0046972388716428!GO:0030660;Golgi-associated vesicle membrane;0.0047338988188106!GO:0005667;transcription factor complex;0.00480790971294023!GO:0002440;production of molecular mediator of immune response;0.00485701759093031!GO:0030097;hemopoiesis;0.00520354993681205!GO:0032640;tumor necrosis factor production;0.00524041863866818!GO:0007034;vacuolar transport;0.00531895451283459!GO:0046930;pore complex;0.00557423913507432!GO:0015662;ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism;0.00609820303954875!GO:0030258;lipid modification;0.00614243904632439!GO:0019318;hexose metabolic process;0.00626608435572113!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;0.00637692726099474!GO:0006367;transcription initiation from RNA polymerase II promoter;0.00664183978626335!GO:0032635;interleukin-6 production;0.00664183978626335!GO:0031497;chromatin assembly;0.00678144662487871!GO:0032561;guanyl ribonucleotide binding;0.00713462939043581!GO:0019001;guanyl nucleotide binding;0.00713462939043581!GO:0030029;actin filament-based process;0.00726925589569265!GO:0050727;regulation of inflammatory response;0.00734204195454489!GO:0031347;regulation of defense response;0.00734204195454489!GO:0032940;secretion by cell;0.00734213683438956!GO:0043087;regulation of GTPase activity;0.00754490125861315!GO:0030218;erythrocyte differentiation;0.00774480113023431!GO:0006612;protein targeting to membrane;0.0077547593412239!GO:0008383;manganese superoxide dismutase activity;0.00780204894681651!GO:0001315;age-dependent response to reactive oxygen species;0.00780204894681651!GO:0009719;response to endogenous stimulus;0.00794731774982164!GO:0008234;cysteine-type peptidase activity;0.00807229838714971!GO:0006665;sphingolipid metabolic process;0.00812532207939721!GO:0045892;negative regulation of transcription, DNA-dependent;0.00814491773203887!GO:0050776;regulation of immune response;0.0082092461860155!GO:0002443;leukocyte mediated immunity;0.008403310832938!GO:0005669;transcription factor TFIID complex;0.00845211921768895!GO:0022415;viral reproductive process;0.0085713522600777!GO:0045408;regulation of interleukin-6 biosynthetic process;0.00864407039199069!GO:0002822;regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains.;0.00864407039199069!GO:0002819;regulation of adaptive immune response;0.00864407039199069!GO:0005743;mitochondrial inner membrane;0.0086633108246058!GO:0030149;sphingolipid catabolic process;0.00869773550619182!GO:0051059;NF-kappaB binding;0.00879900761340289!GO:0002253;activation of immune response;0.00888413485265752!GO:0031625;ubiquitin protein ligase binding;0.00897804906080871!GO:0051329;interphase of mitotic cell cycle;0.00915752379035561!GO:0006334;nucleosome assembly;0.00915816012342048!GO:0005694;chromosome;0.00915816012342048!GO:0005996;monosaccharide metabolic process;0.00916350174229216!GO:0042990;regulation of transcription factor import into nucleus;0.00918854829847666!GO:0042991;transcription factor import into nucleus;0.00918854829847666!GO:0005730;nucleolus;0.00943816122495624!GO:0033673;negative regulation of kinase activity;0.00956153565643558!GO:0006469;negative regulation of protein kinase activity;0.00956153565643558!GO:0016791;phosphoric monoester hydrolase activity;0.00992210994026112!GO:0015631;tubulin binding;0.00994601755468902!GO:0019079;viral genome replication;0.0100709881491444!GO:0007154;cell communication;0.0101623379033798!GO:0050851;antigen receptor-mediated signaling pathway;0.0104072555000241!GO:0016251;general RNA polymerase II transcription factor activity;0.010650321556948!GO:0017091;AU-rich element binding;0.0109694479222405!GO:0050779;RNA destabilization;0.0109694479222405!GO:0000289;poly(A) tail shortening;0.0109694479222405!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.0116673118289517!GO:0006984;ER-nuclear signaling pathway;0.0117219498637163!GO:0008139;nuclear localization sequence binding;0.0118348509731462!GO:0042226;interleukin-6 biosynthetic process;0.0122194362842229!GO:0002467;germinal center formation;0.0123462528937423!GO:0030674;protein binding, bridging;0.0123462528937423!GO:0030127;COPII vesicle coat;0.0124589504801608!GO:0012507;ER to Golgi transport vesicle membrane;0.0124589504801608!GO:0002684;positive regulation of immune system process;0.0124589504801608!GO:0019955;cytokine binding;0.0124802993551809!GO:0032386;regulation of intracellular transport;0.0128533988514947!GO:0002520;immune system development;0.0137624347504388!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0141889027097753!GO:0006690;icosanoid metabolic process;0.0147778640234582!GO:0043405;regulation of MAP kinase activity;0.0147862498085696!GO:0008017;microtubule binding;0.0149214898550561!GO:0004197;cysteine-type endopeptidase activity;0.0149214898550561!GO:0006643;membrane lipid metabolic process;0.0149214898550561!GO:0004428;inositol or phosphatidylinositol kinase activity;0.0154291583364035!GO:0009605;response to external stimulus;0.0155284579887532!GO:0001726;ruffle;0.0156962658040265!GO:0008624;induction of apoptosis by extracellular signals;0.0157453704059976!GO:0016810;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds;0.01575041247616!GO:0048002;antigen processing and presentation of peptide antigen;0.0158953970022191!GO:0019210;kinase inhibitor activity;0.0163465318804609!GO:0030968;unfolded protein response;0.0164181679458936!GO:0015630;microtubule cytoskeleton;0.0164663244669635!GO:0001776;leukocyte homeostasis;0.016997239004606!GO:0006458;'de novo' protein folding;0.016997239004606!GO:0051084;'de novo' posttranslational protein folding;0.016997239004606!GO:0008283;cell proliferation;0.016997239004606!GO:0000278;mitotic cell cycle;0.0170366759544183!GO:0045746;negative regulation of Notch signaling pathway;0.0170839844442147!GO:0051092;activation of NF-kappaB transcription factor;0.0173120989470618!GO:0051348;negative regulation of transferase activity;0.0175026139735747!GO:0008629;induction of apoptosis by intracellular signals;0.0179550453530527!GO:0050778;positive regulation of immune response;0.0182780355596811!GO:0007259;JAK-STAT cascade;0.0184182124805978!GO:0009055;electron carrier activity;0.018564059404009!GO:0009108;coenzyme biosynthetic process;0.018564059404009!GO:0045792;negative regulation of cell size;0.0201394189776724!GO:0048872;homeostasis of number of cells;0.0201394189776724!GO:0051249;regulation of lymphocyte activation;0.020149318373897!GO:0045576;mast cell activation;0.0201767298661719!GO:0005975;carbohydrate metabolic process;0.0201792714985083!GO:0030118;clathrin coat;0.0203819969525964!GO:0050865;regulation of cell activation;0.0205643261627466!GO:0019220;regulation of phosphate metabolic process;0.0207464707026562!GO:0051174;regulation of phosphorus metabolic process;0.0207464707026562!GO:0006368;RNA elongation from RNA polymerase II promoter;0.0208601380518275!GO:0045259;proton-transporting ATP synthase complex;0.0211167515062262!GO:0016070;RNA metabolic process;0.0213172448466566!GO:0001667;ameboidal cell migration;0.0213172448466566!GO:0032027;myosin light chain binding;0.0213172448466566!GO:0050900;leukocyte migration;0.0215607139051335!GO:0045637;regulation of myeloid cell differentiation;0.0217309425720429!GO:0006891;intra-Golgi vesicle-mediated transport;0.0220603870782609!GO:0030521;androgen receptor signaling pathway;0.0226953573909232!GO:0030308;negative regulation of cell growth;0.022698055314729!GO:0045860;positive regulation of protein kinase activity;0.022841893425454!GO:0004860;protein kinase inhibitor activity;0.022841893425454!GO:0005062;hematopoietin/interferon-class (D200-domain) cytokine receptor signal transducer activity;0.022841893425454!GO:0050871;positive regulation of B cell activation;0.0229399023766643!GO:0009117;nucleotide metabolic process;0.0229736749475943!GO:0030659;cytoplasmic vesicle membrane;0.0232614135445267!GO:0019904;protein domain specific binding;0.0236260614656084!GO:0032763;regulation of mast cell cytokine production;0.0238713223196218!GO:0032762;mast cell cytokine production;0.0238713223196218!GO:0045926;negative regulation of growth;0.0240866841163716!GO:0051091;positive regulation of transcription factor activity;0.0240866841163716!GO:0008361;regulation of cell size;0.0240866841163716!GO:0006281;DNA repair;0.0244803861556918!GO:0002237;response to molecule of bacterial origin;0.0253396922879773!GO:0019864;IgG binding;0.0264991269255657!GO:0043488;regulation of mRNA stability;0.0266553210745503!GO:0043487;regulation of RNA stability;0.0266553210745503!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.0270317040847488!GO:0030518;steroid hormone receptor signaling pathway;0.0273243938670386!GO:0051098;regulation of binding;0.0285363445570386!GO:0051347;positive regulation of transferase activity;0.0285942947013008!GO:0030133;transport vesicle;0.028760250017877!GO:0005813;centrosome;0.028760250017877!GO:0050863;regulation of T cell activation;0.028760250017877!GO:0042108;positive regulation of cytokine biosynthetic process;0.0288759857473113!GO:0051252;regulation of RNA metabolic process;0.0291949759365865!GO:0033116;ER-Golgi intermediate compartment membrane;0.0293273950293547!GO:0008654;phospholipid biosynthetic process;0.0295001744641826!GO:0006338;chromatin remodeling;0.0297877917228158!GO:0046979;TAP2 binding;0.0304304270388235!GO:0046977;TAP binding;0.0304304270388235!GO:0046978;TAP1 binding;0.0304304270388235!GO:0033674;positive regulation of kinase activity;0.0304304270388235!GO:0005152;interleukin-1 receptor antagonist activity;0.0304304270388235!GO:0030353;fibroblast growth factor receptor antagonist activity;0.0304304270388235!GO:0002718;regulation of cytokine production during immune response;0.0304304270388235!GO:0002367;cytokine production during immune response;0.0304304270388235!GO:0002700;regulation of production of molecular mediator of immune response;0.0304304270388235!GO:0007040;lysosome organization and biogenesis;0.030775658125747!GO:0005548;phospholipid transporter activity;0.030775658125747!GO:0007041;lysosomal transport;0.0310347500218212!GO:0048534;hemopoietic or lymphoid organ development;0.0312610406876286!GO:0004702;receptor signaling protein serine/threonine kinase activity;0.0312616496719518!GO:0007032;endosome organization and biogenesis;0.0314765704306219!GO:0000118;histone deacetylase complex;0.0322112319210213!GO:0045069;regulation of viral genome replication;0.0322112319210213!GO:0044427;chromosomal part;0.0324748953142828!GO:0007626;locomotory behavior;0.0324748953142828!GO:0009306;protein secretion;0.0326722072848723!GO:0043299;leukocyte degranulation;0.0328655510529004!GO:0012506;vesicle membrane;0.0328655510529004!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.0333540113260761!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.0337922124543185!GO:0042102;positive regulation of T cell proliferation;0.0338118826453243!GO:0030377;U-plasminogen activator receptor activity;0.0340667457641528!GO:0050671;positive regulation of lymphocyte proliferation;0.0341578823318103!GO:0032946;positive regulation of mononuclear cell proliferation;0.0341578823318103!GO:0002444;myeloid leukocyte mediated immunity;0.0341674110385724!GO:0046456;icosanoid biosynthetic process;0.0344479158406126!GO:0006405;RNA export from nucleus;0.0348359134842554!GO:0051325;interphase;0.0349384402989903!GO:0030384;phosphoinositide metabolic process;0.0351123072803144!GO:0001836;release of cytochrome c from mitochondria;0.0352219016619362!GO:0008287;protein serine/threonine phosphatase complex;0.0355338681352997!GO:0004907;interleukin receptor activity;0.0364049950917384!GO:0006260;DNA replication;0.037125702853861!GO:0051049;regulation of transport;0.0373997701861648!GO:0002224;toll-like receptor signaling pathway;0.0378250526096393!GO:0002221;pattern recognition receptor signaling pathway;0.0378250526096393!GO:0002260;lymphocyte homeostasis;0.0380528942187097!GO:0005099;Ras GTPase activator activity;0.0381702952282124!GO:0043300;regulation of leukocyte degranulation;0.038484907841437!GO:0031072;heat shock protein binding;0.0385403619312651!GO:0016363;nuclear matrix;0.0393481679446976!GO:0016584;nucleosome positioning;0.0397182019743565!GO:0030134;ER to Golgi transport vesicle;0.0397182019743565!GO:0043433;negative regulation of transcription factor activity;0.0397182019743565!GO:0048500;signal recognition particle;0.0397182019743565!GO:0004982;N-formyl peptide receptor activity;0.0397182019743565!GO:0016049;cell growth;0.0397182019743565!GO:0051240;positive regulation of multicellular organismal process;0.039854100657629!GO:0008625;induction of apoptosis via death domain receptors;0.0398617335814665!GO:0030041;actin filament polymerization;0.0407039731025739!GO:0002449;lymphocyte mediated immunity;0.0409527304911981!GO:0007033;vacuole organization and biogenesis;0.0411536991187778!GO:0000119;mediator complex;0.0413281624071021!GO:0050811;GABA receptor binding;0.0429414182920479!GO:0001891;phagocytic cup;0.0432489433076947!GO:0019883;antigen processing and presentation of endogenous antigen;0.0434293242008519!GO:0048471;perinuclear region of cytoplasm;0.0434293242008519!GO:0006509;membrane protein ectodomain proteolysis;0.0434543452303607!GO:0033619;membrane protein proteolysis;0.0434543452303607!GO:0051056;regulation of small GTPase mediated signal transduction;0.0435951770285127!GO:0046854;phosphoinositide phosphorylation;0.0435951770285127!GO:0032760;positive regulation of tumor necrosis factor production;0.0439778712819768!GO:0002521;leukocyte differentiation;0.0444017934466423!GO:0000209;protein polyubiquitination;0.045086056439755!GO:0019965;interleukin binding;0.0451957749323564!GO:0045646;regulation of erythrocyte differentiation;0.0454401132563071!GO:0031294;lymphocyte costimulation;0.0455073853906332!GO:0031295;T cell costimulation;0.0455073853906332!GO:0051427;hormone receptor binding;0.0455073853906332!GO:0051085;chaperone cofactor-dependent protein folding;0.0455433391996834!GO:0051188;cofactor biosynthetic process;0.0462196996729395!GO:0000184;mRNA catabolic process, nonsense-mediated decay;0.0462196996729395!GO:0006650;glycerophospholipid metabolic process;0.0462573383416115!GO:0004721;phosphoprotein phosphatase activity;0.0465456012619513!GO:0019207;kinase regulator activity;0.0466612178934901!GO:0030027;lamellipodium;0.0471030666413447!GO:0046834;lipid phosphorylation;0.0473482171493433!GO:0008656;caspase activator activity;0.0473759733332155!GO:0030155;regulation of cell adhesion;0.0473759733332155!GO:0009891;positive regulation of biosynthetic process;0.0477608979103091!GO:0051050;positive regulation of transport;0.0483363429612024!GO:0005869;dynactin complex;0.0483363429612024!GO:0051235;maintenance of localization;0.0483363429612024!GO:0033549;MAP kinase phosphatase activity;0.0483363429612024!GO:0017017;MAP kinase tyrosine/serine/threonine phosphatase activity;0.0483363429612024!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.0486644052200574!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.0486644052200574!GO:0045047;protein targeting to ER;0.0486644052200574!GO:0042771;DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis;0.0488475275275842!GO:0045121;lipid raft;0.0490304114880761!GO:0046488;phosphatidylinositol metabolic process;0.0498139487646475!GO:0004722;protein serine/threonine phosphatase activity;0.0498829203276633!GO:0002218;activation of innate immune response;0.0498829203276633!GO:0002758;innate immune response-activating signal transduction;0.0498829203276633 | |||
|sample_id=12246 | |sample_id=12246 | ||
|sample_note= | |sample_note= |
Revision as of 18:08, 25 June 2012
Name: | Eosinophils, donor3 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12549
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12549
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.162 |
10 | 10 | 0.0786 |
100 | 100 | 0.569 |
101 | 101 | 0.743 |
102 | 102 | 0.918 |
103 | 103 | 0.269 |
104 | 104 | 0.563 |
105 | 105 | 0.134 |
106 | 106 | 4.64773e-4 |
107 | 107 | 0.324 |
108 | 108 | 0.583 |
109 | 109 | 0.193 |
11 | 11 | 0.228 |
110 | 110 | 0.432 |
111 | 111 | 0.378 |
112 | 112 | 0.306 |
113 | 113 | 0.417 |
114 | 114 | 0.0239 |
115 | 115 | 0.199 |
116 | 116 | 0.917 |
117 | 117 | 0.0617 |
118 | 118 | 0.0966 |
119 | 119 | 0.291 |
12 | 12 | 0.423 |
120 | 120 | 0.606 |
121 | 121 | 0.996 |
122 | 122 | 0.666 |
123 | 123 | 0.374 |
124 | 124 | 0.69 |
125 | 125 | 0.183 |
126 | 126 | 0.123 |
127 | 127 | 0.497 |
128 | 128 | 0.0188 |
129 | 129 | 0.517 |
13 | 13 | 0.441 |
130 | 130 | 0.685 |
131 | 131 | 0.667 |
132 | 132 | 0.0999 |
133 | 133 | 0.755 |
134 | 134 | 0.485 |
135 | 135 | 0.187 |
136 | 136 | 0.72 |
137 | 137 | 0.00105 |
138 | 138 | 0.239 |
139 | 139 | 0.11 |
14 | 14 | 0.309 |
140 | 140 | 0.908 |
141 | 141 | 0.504 |
142 | 142 | 0.518 |
143 | 143 | 0.00668 |
144 | 144 | 0.964 |
145 | 145 | 0.796 |
146 | 146 | 0.679 |
147 | 147 | 0.535 |
148 | 148 | 0.121 |
149 | 149 | 0.531 |
15 | 15 | 0.0762 |
150 | 150 | 0.678 |
151 | 151 | 0.268 |
152 | 152 | 0.281 |
153 | 153 | 0.884 |
154 | 154 | 0.906 |
155 | 155 | 0.277 |
156 | 156 | 0.838 |
157 | 157 | 0.961 |
158 | 158 | 0.0124 |
159 | 159 | 0.303 |
16 | 16 | 0.47 |
160 | 160 | 0.769 |
161 | 161 | 0.778 |
162 | 162 | 0.0912 |
163 | 163 | 0.413 |
164 | 164 | 0.171 |
165 | 165 | 0.232 |
166 | 166 | 0.842 |
167 | 167 | 0.998 |
168 | 168 | 0.26 |
169 | 169 | 0.0483 |
17 | 17 | 0.2 |
18 | 18 | 0.122 |
19 | 19 | 0.46 |
2 | 2 | 0.766 |
20 | 20 | 0.606 |
21 | 21 | 0.929 |
22 | 22 | 0.224 |
23 | 23 | 0.00747 |
24 | 24 | 0.525 |
25 | 25 | 0.325 |
26 | 26 | 0.141 |
27 | 27 | 0.798 |
28 | 28 | 0.339 |
29 | 29 | 0.405 |
3 | 3 | 0.333 |
30 | 30 | 0.768 |
31 | 31 | 0.751 |
32 | 32 | 0.72 |
33 | 33 | 0.39 |
34 | 34 | 0.536 |
35 | 35 | 0.134 |
36 | 36 | 0.157 |
37 | 37 | 0.133 |
38 | 38 | 0.402 |
39 | 39 | 0.885 |
4 | 4 | 0.724 |
40 | 40 | 0.237 |
41 | 41 | 0.00493 |
42 | 42 | 0.632 |
43 | 43 | 0.0648 |
44 | 44 | 0.95 |
45 | 45 | 0.403 |
46 | 46 | 0.304 |
47 | 47 | 0.625 |
48 | 48 | 0.634 |
49 | 49 | 0.104 |
5 | 5 | 0.115 |
50 | 50 | 0.877 |
51 | 51 | 0.348 |
52 | 52 | 0.229 |
53 | 53 | 0.301 |
54 | 54 | 0.288 |
55 | 55 | 0.861 |
56 | 56 | 0.609 |
57 | 57 | 0.791 |
58 | 58 | 0.195 |
59 | 59 | 0.0629 |
6 | 6 | 0.729 |
60 | 60 | 0.0289 |
61 | 61 | 0.307 |
62 | 62 | 0.0709 |
63 | 63 | 0.485 |
64 | 64 | 0.491 |
65 | 65 | 0.152 |
66 | 66 | 0.322 |
67 | 67 | 0.574 |
68 | 68 | 0.463 |
69 | 69 | 0.589 |
7 | 7 | 0.218 |
70 | 70 | 0.172 |
71 | 71 | 0.0587 |
72 | 72 | 0.548 |
73 | 73 | 0.35 |
74 | 74 | 0.0561 |
75 | 75 | 0.294 |
76 | 76 | 0.218 |
77 | 77 | 0.489 |
78 | 78 | 0.286 |
79 | 79 | 0.993 |
8 | 8 | 0.976 |
80 | 80 | 0.0268 |
81 | 81 | 0.415 |
82 | 82 | 0.073 |
83 | 83 | 0.0525 |
84 | 84 | 0.587 |
85 | 85 | 0.0654 |
86 | 86 | 0.0358 |
87 | 87 | 0.432 |
88 | 88 | 0.614 |
89 | 89 | 0.148 |
9 | 9 | 0.221 |
90 | 90 | 0.111 |
91 | 91 | 0.445 |
92 | 92 | 0.312 |
93 | 93 | 0.0778 |
94 | 94 | 0.0392 |
95 | 95 | 0.378 |
96 | 96 | 0.344 |
97 | 97 | 0.902 |
98 | 98 | 0.124 |
99 | 99 | 0.0342 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs12549
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000002 in vivo cell sample
FF:0000210 human sample
FF:0000249 human eosinophil- heparinase treated sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000723 (somatic stem cell)
0000048 (multi fate stem cell)
0000988 (hematopoietic cell)
0000548 (animal cell)
0000034 (stem cell)
0002032 (hematopoietic oligopotent progenitor cell)
0000763 (myeloid cell)
0002320 (connective tissue cell)
0002371 (somatic cell)
0000766 (myeloid leukocyte)
0000081 (blood cell)
0000219 (motile cell)
0000134 (mesenchymal cell)
0000738 (leukocyte)
0000255 (eukaryotic cell)
0000094 (granulocyte)
0000037 (hematopoietic stem cell)
0000566 (angioblastic mesenchymal cell)
0000049 (common myeloid progenitor)
0000771 (eosinophil)
0000837 (hematopoietic multipotent progenitor cell)
UBERON: Anatomy
0002384 (connective tissue)
0000479 (tissue)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0001062 (anatomical entity)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA